#35
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians should counsel adolescent and young adult patients who use cannabis about their increased risk of tobacco initiation, as this UC San Diego study demonstrates a significant gateway pattern that affects smoking cessation efforts and overall respiratory health outcomes. Understanding this association helps providers identify high-risk patients early and implement targeted prevention strategies for nicotine addiction alongside cannabis use counseling.
A UC San Diego study presented to San Diego County Supervisors found that approximately 70% of adolescents and young adults who use cannabis subsequently initiate tobacco use, suggesting cannabis may serve as a gateway to tobacco consumption in this population. This epidemiological finding raises clinical concerns about cumulative respiratory and cardiovascular risks when cannabis use precedes or co-occurs with tobacco use in developing adolescent brains and lungs. The research prompted county-level policy attention, indicating that public health officials recognize cannabis use in youth as a potential risk factor for polysubstance use patterns rather than an isolated behavior. For clinicians, this means screening adolescent and young adult cannabis users for concurrent or subsequent tobacco use should be part of comprehensive substance use assessment and counseling. Understanding this gateway pattern helps physicians counsel patients and families about compounding health risks and identify opportunities for early intervention before dual dependence develops.
“We’re seeing some concerning associations in observational data linking cannabis use to tobacco initiation in young people, but I want to be clear that correlation isn’t causation, and we need to understand whether cannabis itself is the driver or if there are shared risk factors we’re not accounting for yet. What this does tell us is that adolescent cannabis exposure deserves serious regulatory attention, particularly around prevention strategies.”
🚬 The emerging evidence that cannabis use may precede tobacco initiation in adolescents and young adults warrants clinical attention, particularly as cannabis policies liberalize in more jurisdictions. While this associational finding from UC San Diego is noteworthy, clinicians should recognize that gateway sequencing does not necessarily imply causation, as shared underlying risk factors—such as sensation-seeking personality, peer influence, or socioeconomic circumstances—likely drive both behaviors. This distinction matters because attributing tobacco use solely to prior cannabis exposure may obscure the multifactorial etiology of substance use and lead to incomplete prevention strategies. In practice, healthcare providers can use this evidence as a prompt to conduct comprehensive substance use screening in young patients who report cannabis use, while avoiding assumptions that cannabis causally drives tobacco adoption. Taking a developmentally informed, non-judgmental approach to understanding the temporal and social context of poly-substance use will better serve adolescents and young
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
📄 Printable 1-Page Physician Patient Guide
Download or print Dr. Benjamin Caplan’s official clinical reference guide to share with your healthcare team.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
